• Please log in or register to access this feature.

Letters to the Editor

The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children

  1. T. T. BISS1,
  2. P. J. AVERY2,
  3. M. D. WILLIAMS3,
  4. L. R. BRANDÃO4,
  5. J. D. GRAINGER5,
  6. F. KAMALI1

Article first published online: 7 FEB 2013

DOI: 10.1111/jth.12072

Issue

Journal of Thrombosis and Haemostasis

Journal of Thrombosis and Haemostasis

Volume 11, Issue 2, pages 373–375, February 2013

Additional Information

How to Cite

Biss TT, Avery PJ, Williams MD, Brandão LR, Grainger JD, Kamali F. The VKORC1 and CYP2C9 genotypes are associated with over-anticoagulation during initiation of warfarin therapy in children. J Thromb Haemost 2013; 11: 373–5. Doi:10.1111/jth.12072

Author Information

  1. 1

    Institute of Cellular Medicine, Newcastle University

  2. 2

    School of Mathematics & Statistics, Newcastle University, Newcastle upon Tyne

  3. 3

    Department of Haematology, Birmingham Children's Hospital, Birmingham, UK

  4. 4

    Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada

  5. 5

    Department of Haematology, Royal Manchester Children's Hospital, Manchester, UK

*Correspondence: Tina Biss, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.Tel.: +44 191 2829516; fax: +44 191 2820814.E-mail: tina.biss@ncl.ac.uk

Publication History

  1. Issue published online: 7 FEB 2013
  2. Article first published online: 7 FEB 2013
  3. Accepted manuscript online: 27 DEC 2012 04:10AM EST
  4. Manuscript Accepted: 8 NOV 2012
  5. Manuscript Received: 26 OCT 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS